Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (964)
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
171,963
Price
$15.77
Total Value
$2.71M
Shares Held After
2,567,245
% of Holdings
6.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.55
Total Value
$277.32K
Shares Held After
399,484
% of Holdings
4.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
9
Price
$168.35
Total Value
$1.52K
Shares Held After
12,666
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
16
Price
$167.16
Total Value
$2.67K
Shares Held After
12,675
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$166.91
Total Value
$500.72
Shares Held After
12,691
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
40
Price
$165.29
Total Value
$6.61K
Shares Held After
12,694
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
124
Price
$164.40
Total Value
$20.39K
Shares Held After
12,734
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
524
Price
$163.52
Total Value
$85.68K
Shares Held After
12,858
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
284
Price
$162.76
Total Value
$46.22K
Shares Held After
13,382
% of Holdings
2.1%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
1,750
Price
$105.47
Total Value
$184.57K
Shares Held After
59,003
% of Holdings
2.9%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
125,274
Price
$20.07
Total Value
$2.51M
Shares Held After
4,207,525
% of Holdings
2.9%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
94,462
Price
$0.75
Total Value
$70.85K
Shares Held After
83,359
% of Holdings
53.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$586.47
Total Value
$23.46K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
163
Price
$585.50
Total Value
$95.44K
Shares Held After
40,553
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$584.39
Total Value
$297.45K
Shares Held After
40,716
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
848
Price
$583.41
Total Value
$494.74K
Shares Held After
41,225
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$582.46
Total Value
$623.23K
Shares Held After
42,073
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
238
Price
$585.36
Total Value
$139.32K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$581.71
Total Value
$238.50K
Shares Held After
43,143
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
482
Price
$584.49
Total Value
$281.73K
Shares Held After
19,114
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,009
Price
$583.55
Total Value
$588.80K
Shares Held After
19,596
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$579.92
Total Value
$160.64K
Shares Held After
43,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$579.09
Total Value
$266.96K
Shares Held After
43,830
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
983
Price
$582.47
Total Value
$572.57K
Shares Held After
20,605
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
488
Price
$581.66
Total Value
$283.85K
Shares Held After
21,588
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$577.94
Total Value
$95.36K
Shares Held After
44,291
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
340
Price
$579.86
Total Value
$197.15K
Shares Held After
22,076
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,148
Price
$576.87
Total Value
$662.25K
Shares Held After
44,456
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
500
Price
$578.90
Total Value
$289.45K
Shares Held After
22,416
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,179
Price
$575.96
Total Value
$679.05K
Shares Held After
45,604
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
687
Price
$577.27
Total Value
$396.58K
Shares Held After
22,916
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$575.07
Total Value
$327.79K
Shares Held After
46,783
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,398
Price
$576.37
Total Value
$805.77K
Shares Held After
23,603
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,683
Price
$573.57
Total Value
$965.31K
Shares Held After
47,353
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,010
Price
$575.41
Total Value
$581.16K
Shares Held After
25,001
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
977
Price
$572.41
Total Value
$559.24K
Shares Held After
49,036
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
442
Price
$574.09
Total Value
$253.75K
Shares Held After
26,011
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,543
Price
$573.45
Total Value
$884.83K
Shares Held After
26,453
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
880
Price
$572.33
Total Value
$503.65K
Shares Held After
27,996
% of Holdings
3.0%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,690
Price
$3.88
Total Value
$157.97K
Shares Held After
12,114,700
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
15,000
Price
$23.61
Total Value
$354.15K
Shares Held After
362,152
% of Holdings
4.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Zivo Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
100,000
Price
$2.00
Total Value
$200.00K
Shares Held After
572,942
% of Holdings
17.5%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,441
Price
$48.06
Total Value
$117.30K
Shares Held After
25,000
% of Holdings
8.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,419
Price
$47.39
Total Value
$114.64K
Shares Held After
27,441
% of Holdings
8.1%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
140
Price
$45.81
Total Value
$6.41K
Shares Held After
29,860
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
426,005
Price
$40.32
Total Value
$17.18M
Shares Held After
6,709,228
% of Holdings
6.0%
Showing 51–100 of 964 transactions (page 2 of 20)